Going forward, 24,900 remains a crucial support level for the index; a decisive fall below this level is likely to empower ...

On Monday, India’s benchmark indices staged a strong turnaround after an early slip. The Sensex rebounded from a morning low ...

As quarterly results are out for Bank Nifty giants like HDFC Bank and ICICI Bank, traders are capitalising on result ...

Wayfair (NYSE:W) is gearing up to release its second-quarter earnings before the market opens on August 4, with expectations ...

Opendoor's weak fundamentals, fierce competition, and sluggish housing trends pose risks despite meme stock momentum. Learn ...

Alphabet's stock is entering earnings day on Wednesday strong, having gained about 14% in the past month. But you wouldn't ...

ADI shares flashed a Golden Cross pattern on July 1, when the 50-day moving average crossed above the 200-day, a classic ...

StoneCo is no longer the broken company the market remembers. I see a clear path to a $30 valuation. With profitability ...

The Invesco QQQ Trust Series I QQQ, an ETF that tracks the Nasdaq-100, was also poised for another record finish on Monday. This content was created by MarketWatch, which is operated by Dow Jones & Co ...

Consumers have shifted. With recession fears rising and tariffs threatening to push prices higher, value is now king, and ...

With data as of July 18, 2025, we examine if Barclays PLC(BCS) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.